These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10223683)

  • 21. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
    Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
    J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The launching of a cytomegalovirus vaccine.
    Hanshaw JB
    Am J Dis Child; 1982 Apr; 136(4):291-2. PubMed ID: 6280489
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against Herpes group viruses, in particular, cytomegalovirus.
    Plotkin SA
    Monogr Paediatr; 1979; 11():58-74. PubMed ID: 226876
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge.
    Plotkin SA; Starr SE; Friedman HM; Gönczöl E; Weibel RE
    J Infect Dis; 1989 May; 159(5):860-5. PubMed ID: 2540247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus vaccine: timing is important.
    Griffiths PD
    Rev Med Virol; 2018 Jul; 28(4):e1986. PubMed ID: 29921027
    [No Abstract]   [Full Text] [Related]  

  • 27. Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
    John S; Yuzhakov O; Woods A; Deterling J; Hassett K; Shaw CA; Ciaramella G
    Vaccine; 2018 Mar; 36(12):1689-1699. PubMed ID: 29456015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for the clinical management of human cytomegalovirus infections.
    Farrar GH; Bull JR; Greenaway PJ
    Vaccine; 1986 Dec; 4(4):217-24. PubMed ID: 3026105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates.
    Sachs GW; Simmons RL; Balfour HH
    Vaccine; 1984 Sep; 2(3):215-8. PubMed ID: 6099649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial.
    Glazer JP; Friedman HM; Grossman RA; Starr SE; Barker CF; Perloff LJ; Huang ES; Plotkin SA
    Ann Intern Med; 1979 Nov; 91(5):676-83. PubMed ID: 227299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
    Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
    J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoprophylaxis of experimental cytomegalovirus infection.
    Minamishima Y
    Ann Microbiol (Paris); 1977 Oct; 128(3):399-407. PubMed ID: 203216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in vaccine development for prevention of human cytomegalovirus infection.
    Gönczöl E; Plotkin S
    Curr Top Microbiol Immunol; 1990; 154():255-74. PubMed ID: 2161323
    [No Abstract]   [Full Text] [Related]  

  • 35. Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein.
    Pande H; Campo K; Tanamachi B; Forman SJ; Zaia JA
    Scand J Infect Dis Suppl; 1995; 99():117-20. PubMed ID: 8668934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
    Adler SP; Hempfling SH; Starr SE; Plotkin SA; Riddell S
    Pediatr Infect Dis J; 1998 Mar; 17(3):200-6. PubMed ID: 9535246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection.
    Alford CA
    Ala J Med Sci; 1985 Apr; 22(2):169-89. PubMed ID: 2988358
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytomegalovirus vaccine live (Pasteur Mérieux Connaught).
    Drugs R D; 1999 Nov; 2(5):310-2. PubMed ID: 10728468
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immunity to cytomegalovirus in mice and in renal transplant recipients.
    Howard RJ; Balfour HH
    Transplant Proc; 1979 Mar; 11(1):75-8. PubMed ID: 222021
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.
    Plotkin SA; Starr SE; Friedman HM; Brayman K; Harris S; Jackson S; Tustin NB; Grossman R; Dafoe D; Barker C
    Ann Intern Med; 1991 Apr; 114(7):525-31. PubMed ID: 1848053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.